USPTO serial 77709614
ESCUELA GNOSTICA UNIVERSAL (E.G.U.)
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FINNEGAN, TIMOTHY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ESCUELA GNOSTICA UNIVERSAL (E.G.U.)?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Urruticoechea Velasco, Jose Ignacio
Alhaurin de la Torre, ES
Other trademarks owned by Urruticoechea Velasco, Jose Ignacio
Urruticoechea Velasco, Jose Ignacio
Alhaurin de la Torre, ES
Other trademarks owned by Urruticoechea Velasco, Jose Ignacio
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lawrence E. Abelman
Dennis H. Cavanaugh Abelman Frayne & Schwab666 3RD AVE10th FloorNEW YORK, NY 10017-4046Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Bandages impregnated with a pharmaceutical or therapeutic substance, namely, natural plants, minerals and vitamins; Biometallic compounds used as component in pharmaceutical preparations for the treatment of respiratory diseases and disorders, infectious diseases, hormonal disorders and for the prevention of osteoporosis, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, ocular disorders or diseases, bacteria-based diseases, diabetes, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for tablets and capsules that facilitates the delivery of pharmaceuticals; Homeopathic pharmaceuticals for use in treatment of respiratory diseases and disorders, infectious diseases, hormonal disorders and for the prevention of osteoporosis, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, ocular disorders or diseases, bacteria-based diseases, diabetes, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of hormonal disorders and for the prevention of osteoporosis; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, Pharmaceutical preparations for skin care; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical skin lotions; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes | ACTIVE | — |
| 041 | Educational services, namely, classes, seminars, workshops and lectures in the fields of medical, homeopathic and pharmaceutical procedures and medical, homeopathic and pharmaceutical treatments; teaching, training, tutoring and courses of instruction at the undergraduate, graduate, and post-graduate level | ACTIVE | — |
| 044 | Medical and pharmaceutical consultation; health care services, namely, hospitals, long term care facilities, medical clinics, wellness centers, namely, medical clinics, wellness programs; health maintenance organizations and managed health care services organizations; Chiropractic services; and psychological consultation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Urruticoechea Velasco, Jose Ignacio
- Other trademarks owned by Urruticoechea Velasco, Jose Ignacio
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named ESCUELA GNOSTICA UNIVERSAL (E.G.U.)
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 16, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 13, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 19, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 13, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 11, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 10, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 10, 2011 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 4, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 24, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 20, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 20, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 20, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 29, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 29, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 30, 2010 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 30, 2010 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 30, 2010 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 29, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jan 21, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2010 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 21, 2010 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 4, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 4, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 4, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 14, 2009 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Apr 13, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2009 | NWAP | NEW APPLICATION ENTERED | — |